Skip to main content
Clinical Trials/CTRI/2018/05/013920
CTRI/2018/05/013920Active, not recruitingNot Applicable

Effect of single shot intravenous dexmedetomidine for the supplementation of caudal analgesia in children - a prospective randomized comparative study.

AIIMS1 site in 1 country60 target enrollmentStarted: August 8, 2016Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Active, not recruiting
Sponsor
AIIMS
Enrollment
60
Locations
1
Primary Endpoint
To assess the effect of intravenous dexmedetomidine on caudal analgesia , to compare the time to rescue analgesia.

Study Overview

Brief Summary

Dexmedetomidine is a short acting selective alpha 2 agonist with sedative anxiolytic and analgesic properties. It has been used as adjunct to general and regional anaesthesia in adults.In adults, there are studies showing analgesic action of  Intravenous dexmedetomidine on epidural block.

After a vast literature search ,we found that there are limited studies on the effect of intravenous dexmedetomidine on caudal analgesia in children. We hypothesis that intravenous dexmedetomidine might prolong the caudal analgesia in children. Hence we planned to conduct this study to evaluate the efficacy of intravenous dexmedetomidine for the supplementation of caudal analgesia in children.

the study results is statistically significant increase duration of analgesia with dexmedetomidine group of mean duration  425 minutes  and that of saline group of 300 minutes

Study Design

Study Type
Interventional
Allocation
Computer generated randomization
Masking
Participant, Investigator and Outcome Assessor Blinded

Eligibility Criteria

Ages
2.00 Year(s) to 8.00 Year(s) (—)
Sex
All

Inclusion Criteria

  • •ASA I-II Age 2- 8 yrs Undergoing urethroplasty.

Exclusion Criteria

  • •Parental or guardian refusal Hypersensitivity to any local anaesthetic Bleeding diathesis Infection at puncture site Children with uncorrected heart disease Children with heart block or liver impairment Preexisting neurological diseases.

Outcomes

Primary Outcomes

To assess the effect of intravenous dexmedetomidine on caudal analgesia , to compare the time to rescue analgesia.

Time Frame: The duration of analgesia is from the time of caudal injection to the time of FLACC score 4.

Secondary Outcomes

  • To compare the incidence of emergence agitation(To compare the time for discharge based on modified aldrete score.)

Investigators

Sponsor
AIIMS
Sponsor Class
Research institution and hospital

Study Sites (1)

Loading locations...

Similar Trials